SCHEMBL7387

SCHEMBL7387

Cc1noc(-c2ccc(Br)cc2)c1C(CO)Sc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.35
LPAR1 Q92633 3/20 0.34
LPAR3 Q9UBY5 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33
NOTUM Q6P988 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
BRD4 O60885 2/20 0.32
CYP2C9 P11712 2/20 0.32
ABCC3 O15438 1/20 0.32
ABCC4 O15439 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6698 0.85 MEN1 (0.38) ALDH1A1SMN1; SMN2MAPTRAB9ATDP1
SCHEMBL2087 0.84 EPHX1 (0.35) LPAR1LPAR3ALDH1A1SMN1; SMN2MAPT
SCHEMBL6943 0.84 EPHX1 (0.35) LPAR1LPAR3ALDH1A1SMN1; SMN2MAPT
SCHEMBL11802 0.81 CYP1A2 (0.33) ALDH1A1SMN1; SMN2MAPTRAB9ATDP1
SCHEMBL6561 0.80 LPAR1 (0.34) NR1I2LPAR1LPAR3ALDH1A1SMN1; SMN2
SCHEMBL7386 0.79 SMN1; SMN2 (0.38) NR1I2LPAR1LPAR3ALDH1A1SMN1; SMN2
SCHEMBL6814 0.78 CYP1A2 (0.31) TDP1CYP2C9CYP1A2CYP3A4CYP2C19
SCHEMBL1925 0.74 LPAR1 (0.36) LPAR1LPAR3ALDH1A1SMN1; SMN2MAPT
SCHEMBL1909 0.74 LPAR1 (0.36) LPAR1LPAR3ALDH1A1SMN1; SMN2MAPT
SCHEMBL6734 0.74 ADRB2 (0.38) LPAR1LPAR3ALDH1A1SMN1; SMN2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed